Skip to main content
. 2020 Jul 2;12(7):616. doi: 10.3390/pharmaceutics12070616

Figure 4.

Figure 4

Gene-based therapeutic approaches for targeting faulty CFTR using different methods: (a) antisense oligonucleotide, (b) gene editing, and (c) gene replacement.